Identifies potential SARS-CoV-2 3CLpro inhibitors using machine learning, suggesting new antiviral candidates.
, were identified as major nodes linking compound action to antiviral and immune processes. This study delivers a combinatorial computational pipeline to accelerate the discovery of 3CLpro-targeted antivirals, providing mechanistic insights and a shortlist of candidates for future experimental validation.
No takes yet. Share an insight, caveat, or question.
Manaithiya et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: